Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
British Journal of Cancer
|
February 3, 2005
Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP
J Cummings, T H Ward, E LaCasse, et al.
British Journal of Cancer
|
February 25, 2009
Biomarkers of apoptosis
T H Ward, J Cummings, E Dean, et al.
Journal of Immunological Methods
|
June 16, 2010
Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects
G Hampson, T H Ward, J Cummings, et al.
Experimental Cell Research
|
February 14, 2002
Electrochemical monitoring of anticancer compounds on the human ovarian carcinoma cell line A2780 and its adriamycin- and Cisplatin-resistant variants
D E Woolley, L C Tetlow, D J Adlam, et al.
Carcinogenesis
|
March 1, 1992
Upregulation of O6-alkylguanine-DNA-alkyltransferase expression and the presence of double minute chromosomes in alkylating agent selected Chinese hamster cells
J E Morten, L Bayley, A J Watson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 6, 2004
Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation
Joo-Young Kim, C M L West, H Valentine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2011
Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1
S J Danson, P Johnson, T H Ward, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2001
Short tandem repeat profiling provides an international reference standard for human cell lines
J R Masters, J A Thomson, B Daly-Burns, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
British Journal of Cancer
|
February 3, 2005
Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP
J Cummings, T H Ward, E LaCasse, et al.
British Journal of Cancer
|
February 25, 2009
Biomarkers of apoptosis
T H Ward, J Cummings, E Dean, et al.
Journal of Immunological Methods
|
June 16, 2010
Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects
G Hampson, T H Ward, J Cummings, et al.
Experimental Cell Research
|
February 14, 2002
Electrochemical monitoring of anticancer compounds on the human ovarian carcinoma cell line A2780 and its adriamycin- and Cisplatin-resistant variants
D E Woolley, L C Tetlow, D J Adlam, et al.
Carcinogenesis
|
March 1, 1992
Upregulation of O6-alkylguanine-DNA-alkyltransferase expression and the presence of double minute chromosomes in alkylating agent selected Chinese hamster cells
J E Morten, L Bayley, A J Watson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 6, 2004
Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation
Joo-Young Kim, C M L West, H Valentine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2011
Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1
S J Danson, P Johnson, T H Ward, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 21, 2001
Short tandem repeat profiling provides an international reference standard for human cell lines
J R Masters, J A Thomson, B Daly-Burns, et al.
Page
of 4